NYSE:ELVHealthcare
Elevance Health (ELV) Is Up 6.7% After Raising 2026 EPS Outlook And Boosting Capital Returns – Has The Bull Case Changed?
Earlier this week, Elevance Health reported first-quarter 2026 results with revenue of US$50.18 billion and net income of US$1.76 billion, while also declaring a second-quarter dividend of US$1.72 per share and updating full-year 2026 diluted EPS guidance to at least US$19.85.
Beneath the headline numbers, the quarter featured earnings that exceeded analyst expectations, a higher adjusted EPS outlook, and ongoing support from share repurchases that reduced the share count by 3,700,000 in the...